Skip to main content

Application and Innovation of Multiomics Technologies in Clinical Oncology

224kviews
Editorial28 March 2023
Editorial: Application and innovation of multiomics technologies in clinical oncology

This special issue entitled "Application and Innovation of Multiomics Technologies in Clinical Oncology" compiled 43 articles, highlighting different applications and findings using genomics, transcriptomics and multiomics in a wide range of cancer types. One of the powerful and common omics'applications is its ability to identify molecular signatures and biomarkers for cancer classification, metastasis, prognosis and treatment. This special issue provides ample examples of such, including miR-139-5p and a 3-miRNA signature as potential biomarkers for subtyping breast carcinoma (Sun H et al., 2022 Mar 31;12:857714) and predicting survival in nasopharyngeal carcinoma (Zhou JH et al, 2022 Jan 27;11:823603), LncRNA-AC02278.4 and ASF1B as Prognostic Biomarkers for Tumor Growth and Metastasis in Lung Adenocarcinoma (Chen X et al., 2022 Apr 6;12:860961), and poor outcome in the HBV-infected hepatocellular carcinoma (Wang X et al., 2022 Feb 24;12:838845), immune-related and energy metablolism-related gene signatures with prognostic potential for pancreatic cancer (Chen R et al., 2022 Apr 27;12:841530) and hepatocellular carcinoma (Liu H et al., 2022 Sep 29;12:917897).Of particular interest, Huang ZL et al (2022 May 30;12:878923) used univariable Cox regression analyses and differential gene expression analysis with bulk RNAseq data to identify eight genes that are closely associated with the recurrence-free survivals (RFS) of HCC patients in both training and three validation cohorts. They subsequently built a multivariable Cox model based on the expression of these genes to predict the risk of HCC recurrence. The results showed that the Eight-Gene Cox (EGC) model outperformed other published models and could serve as independent predictor in predicting HCC recurrence. Furthermore, the authors investigated the cell-type-specific expression patterns and their biological functions of these eight marker genes in tumor microenvironment using single-cell RNA sequencing data. Interestingly, these genes had different expression patterns in different cell types. For example, PLCB1 and SLC22A7 were predominantly expressed in malignant cells while FASLG and IL2RB were specifically expressed in T cells, suggesting their functional roles in these given cell types.The results of this study are not only significant in terms of providing a novel model for HCC recurrence prediction but also in shedding light on the underlying mechanisms behind HCC recurrence. It demonstrates the importance of the tumor microenvironment and highlights the need for a more comprehensive understanding of the interplay between tumor cells and their surrounding microenvironment in cancer development and progression. The insights gained into the functional roles of the HCC recurrence marker genes provide clues for further research and the development of new therapeutic strategies for the treatment of HCC.In addition to gene expression signatures and biomarkers, the DNA markers are equally informative for predicting treatment efficacy, toxicity and clinical outcome. He K et al. (2022 Jul 14;12:928605) identified genetic determinants that can explain individual variations in radiosensitivity and radiotherapy-associated toxicity in 122 patients with unresectable stage III nonsmall-cell lung cancer (NSCLC). The research confirmed previously reported genetic association with clinical outcomes and also identified the FGFR family genes, MET, PTEN, and NOTCH2 as potential novel and independent risk factors of poor post-CRT survival by using a 474-cancer and radiotherapy-related gene panel. These novel biomarkers may offer new therapeutic targets for patients with NSCLC. The identification of genetic markers in relation to radiotherapyassociated thoracic toxicity is critical for the design of better treatment strategies to reduce or eliminate the risk of toxicities associated with CRT.This study has several important clinical implications. It demonstrated the clinical utility of focused NGS panels in identifying predictive biomarkers for response to CRT, reinforced the importance of pre-treatment genetic information to better inform CRT outcomes and clinical actions in stage III unresectable NSCLCs, and stressed that integrated analysis of multiple alterations can lead to improved stratification of the risk populations.The utilization of a multi-omics approach has also facilitated the comprehension of molecular pathways, mechanisms, and mechanistic models for tumor development by compiling various types of data and constructing new data-driven concepts. In this research topic, such efforts were documented and published for several common and rare cancers, including colon (Want Sh et al., 2022 Mar 15;12:857148.), gastric (Gao WC and Yang M, 2022 May 4;12:881015), bladder (Mao YP et al., 2022 Feb 25;12:835074), nasopharyngeal carcinoma (Lu X et al., 2022 Jul 26;12:965088), and adult spinal intramedullary astrocytomas (Konovalov N et al., 2022 Mar 21;12:837570), the latter paper is supplemented with the first-of-its-kind collection of experimental RNAseq profiles for this orphan cancer.As the field of omics continues to evolve and expand, a multiomics approach is becoming increasingly important for advancing our understanding of complex diseases such as cancer. By embracing a multiomics approach that combine and integrate multiple layers of molecular information, we can accelerate the pace of discovery and translation of omics research into clinical practice in cancer.

1,267 views

2 citations

ORIGINAL RESEARCH
6 March 2023
The bioinformatic approach identifies PARM1 as a new potential prognostic factor in osteosarcoma
Haijun Feng, 2 more and Shengbao Wang

3,497 views

2 citations

LASSO-based screening for potential prognostic biomarkers associated with glioblastoma
ORIGINAL RESEARCH
16 January 2023
LASSO-based screening for potential prognostic biomarkers associated with glioblastoma
Yin Tian, 1 more and Yun Jiang
Glioblastoma is the most common malignancy of the neuroepithelium, yet existing research on this tumor is limited. LASSO is an algorithm of selected feature coefficients by which genes associated with glioblastoma prognosis can be obtained. Glioblastoma related data were selected from the The Cancer Genome Atlas database, and information was obtained for a total of 158 samples, including 153 cancer samples and five samples of paracancerous tissue. And 2,642 normal samples were selected from the Genotype-Tissue Expression database. Whole gene bulk survival analysis and differential expression analysis were performed on glioblastoma genes then their intersection was taken and Finally we obtained the genes associated with glioma prognosis.The STRING database was used to analyze the interaction network between genes, and the MCODE plugin under Cytoscape was used to identify the highest-scoring clusters. LASSO prognostic analysis was performed to obtain key genes. Gene expression validation allowed us to obtain genes with significant expression differences in glioblastoma cancer samples and paracancer samples, and glioblastoma independent prognostic factors could be derived by univariate cox and multivariate cox analysis. GO functional enrichment analysis was performed, and the expression of the screened genes was detected using qRT-PCR. Whole-gene bulk survival analysis of glioblastoma genes yielded 607 genes associated with glioblastoma prognosis, differential expression analysis yielded 8,801 genes, and the intersection of prognostic genes with differentially expressed genes yielded 323 intersecting genes. PPI analysis of the intersecting genes revealed that the genes were significantly enriched in functions such as the formation of a pool of free 40S subunits and placenta development, and the highest-scoring clusters were obtained using the MCODE plug-in. Eight genes associated with glioblastoma prognosis were identified based on LASSO analysis: RPS10, RPS11, RPS19, RSL24D1, RPL39L, EIF3E, NUDT5, and RPF1. All eight genes were found to be highly expressed in the tumor by gene expression verification, and in addition, univariate cox and multivariate cox analyses were performed on these eight genes to identify RPL39L and NUDT5 as two independent prognostic factors associated with glioblastoma. Both RPL39L and NUDT5 were highly expressed in glioblastoma cells. Two independent prognostic factors in glioblastoma, RPL39L and NUDT5, were identified.

4,412 views

10 citations

ORIGINAL RESEARCH
13 February 2023
Wnt signaling pathway-related gene PRICKLE1 is a prognostic biomarker for esophageal squamous cell carcinoma
Jinxian He, 6 more and Weiyu Shen

2,634 views

3 citations

ORIGINAL RESEARCH
14 December 2022
Identification of prognosis-related gene features in low-grade glioma based on ssGSEA
Yuanzhi He, 1 more and Sanyang Tan

3,080 views

8 citations

ORIGINAL RESEARCH
14 December 2022
Analysis of the regulatory mechanisms of prognostic immune factors in thyroid cancer
Yin Tian, 1 more and Xue Sun

2,928 views

8 citations

4,826 views

13 citations

MIR4435-2HG in exosomes promotes gastric carcinogenesis by inducing M2 polarization in macrophages
ORIGINAL RESEARCH
22 November 2022
MIR4435-2HG in exosomes promotes gastric carcinogenesis by inducing M2 polarization in macrophages
Chaofeng Li, 8 more and Tao Fu
Gastric cancer (GC) is a cancer with a high mortality rate. lncRNAs play a role in regulating GC tumorigenesis. In this paper, we analyzed differentially expressed lncRNAs between GC and adjacent normal tissues using multiple bioinformatics tools to identify new potential targets in GC. Cell viability and migration ability were detected using the Cell Counting Kit-8 (CCK-8) and transwell assays, MIR4435-2HG was negatively correlated with the survival rate of GC patients, and by inhibiting the activity of MIR4435-2HG, the viability and migration ability of GC cells could be reduced. In addition, RT- qPCR and western blot to detect gene and protein level expression, transmission electron microscopy and nanoparticle tracking analysis (NTA) to study the efficiency of exosome isolation, and flow cytometry to observe cell differentiation were employed, delivery of MIR4435-2HG shRNA via MKN45 cell-derived exosomes significantly reversed the MKN45 exosome-induced M2 polarization in macrophages. Furthermore, the low expression of MIR4435-2HG in MKN45 cell-derived exosomes inhibited the Jagged1/Notch and JAK1/STAT3 pathways in macrophages; MIR4435-2HG downregulated exosomes were found to significantly inhibit GC tumor growth in vivo by establishing a mouse model. In short, MKN45 cell-derived exosomes deliver lncRNA MIR4435-2HG, which promotes gastric carcinogenesis by inducing macrophage M2 polarization.

3,508 views

35 citations

ORIGINAL RESEARCH
29 November 2022
PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression
Jianzhong Peng, 3 more and Peng Xiao

3,153 views

12 citations

OBJECTIVE: Brain metastasis is a primary cause of morbidity and mortality in breast cancer patients. Therefore, elucidation and understanding of the underlying mechanisms are essential for the development of new therapeutic strategies. METHODS: Differential gene analysis was performed for those with and without distant metastasis in The Cancer Genome Atlas (TCGA) database and those with and without recurrence in the brain in the dataset GSE12276. The differentially expressed genes procured from the two databases were intersected to obtain the intersecting genes associated with brain metastasis. Thereafter, the intersecting genes were subjected to LASSO model construction to screen for prognostic genes. The expression of the obtained genes in metastatic breast cancer was observed, and survival analysis was performed. Finally, GSEA analysis of the obtained genes was performed, and the relationship between them and immune cells was explored. RESULTS: A total of 335 differential genes for the occurrence of distant metastases were obtained based on the TCGA database. A total of 1070 differential genes for recurrence to the brain were obtained based on the dataset GSE12276. The Venn diagram showed 24 intersecting genes associated with brain metastasis. The LASSO prognostic model contained a total of five genes (GBP2, GPR171, DIRAS3, RAC2, and CACNA1D). Expression difference analysis showed that GBP2, GPR171, DIRAS3, and RAC2 were significantly down-regulated in expression in metastatic breast cancer compared with primary breast cancer tumors. Only GPR171, DIRAS3, and RAC2 were strongly correlated with the overall survival of breast cancer patients. Their correlation analysis with immune cells showed that the correlation coefficient between the expression levels of DIRAS3 and immune cells was low, and the expression levels of GPR171 and RAC2 were more closely correlated with B cells and macrophages. CONCLUSIONS: The expression of DIRAS3, GPR171 and RAC2, genes associated with brain metastasis, was reduced in metastatic breast cancer, and GPR171 was found to promote brain metastasis of breast cancer cells by inducing B cells and thereby.

4,129 views

13 citations

Single-cell transcriptome analysis reveals T-cell exhaustion in denosumab-treated giant cell tumor of bone
ORIGINAL RESEARCH
12 September 2022
Single-cell transcriptome analysis reveals T-cell exhaustion in denosumab-treated giant cell tumor of bone
Meiling Yang, 4 more and Changye Zou
Denosumab (DMAB), a human monoclonal antibody against the receptor activator of the nuclear factor-kappa B ligand, is used for the treatment for unresectable giant cell tumor of bone (GCTB). However, little is known about the molecular and functional characteristics of GCTB-infiltrating lymphocytes after DMAB treatment. Here, we performed single-cell RNA sequencing and immunostaining assays to delineate the immune landscape of GCTB in the presence and absence of DMAB. We found that exhausted CD8+ T cells were preferentially enriched in DMAB-treated GCTB. A distinct M2-skewed type of tumor-associated macrophages (TAMs) comprises the majority of GCTB TAMs. We identified cytokines, including interleukin-10, and inhibitory receptors of M2 TAMs as important mediators of CD8+ T cell exhaustion. We further revealed that DMAB treatment notably increased the expression levels of periostin (POSTN) in GCTB cells. Furthermore, POSTN expression was transcriptionally regulated by c-FOS signaling and correlated with GCTB recurrence in patients after DMAB treatment. Collectively, our findings reveal that CD8+ T-cells undergo unappreciated exhaustion during DMAB therapy and that GCTB cell-derived POSTN educates TAMs and establishes a microenvironmental niche that facilitates GCTB recurrence.

7,548 views

11 citations

ORIGINAL RESEARCH
15 September 2022
lncRNA NEAT1 promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the FOXP3/PKM2 axis
Junping Pan, 3 more and Xinhua Zhu

2,867 views

15 citations

Comprehensive prognostic and immunological analysis of CCT2 in pan-cancer
ORIGINAL RESEARCH
1 September 2022
Comprehensive prognostic and immunological analysis of CCT2 in pan-cancer
Wenming Lv, 2 more and Shengbao Wang
CCT2 acts as a molecular chaperone protein that assists in the proper folding of proteins, thus ensuring a dynamic balance of cellular homeostasis. Despite the increasing evidence supporting the important role of CCT2 in the tumorigenesis of certain cancers, few articles have been published to provide a systematic pan-cancer analysis of CCT2. Hence, to evaluate the expression status and prognostic significance of CCT2 in pan-cancers. An analysis of the relationship between CCT2 and different tumor immune cell infiltrations was conducted using datasets from the Cancer Genome Atlas, Cancer Cell Lineage Encyclopedia and so on. In most cancers, CCT2 expression was high and was associated with poor prognosis. Moreover, CCT2 gene expression was negatively correlated with infiltration of most immune cells in 10 cancer types, and CCT2 expression was related to tumor mutation burden (TMB) and microsatellite instability (MSI). The role that CCT2 plays in tumorigenesis and tumor immunity suggests that it can serve as a prognostic marker in many cancers.

3,516 views

19 citations

ORIGINAL RESEARCH
2 September 2022
HOXA1 is a radioresistance marker in multiple cancer types
Lu He, 3 more and Yi Yu

3,424 views

10 citations

ORIGINAL RESEARCH
9 August 2022
The global change of gene expression pattern caused by PTEN mutation affects the prognosis of glioblastoma
Shengjun Zhou, 3 more and Zhiqing Lin

3,208 views

6 citations

ORIGINAL RESEARCH
2 August 2022
Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma
Xiao-Ren Zhu, 7 more and Yi-Ping Du

5,042 views

13 citations